Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nucleus (PVN) leading to hyperphagia. PRL may also act through the inhibition of anorexigenic effect of leptin via induction of suppressor of cytokine signaling 3 (SOCS-3). This paper aimed to co-localize PRL (PRL-R) and leptin (ObRb) receptors in the hypothalamus of female rats and investigate the possible cross-desensitization between PRL-R and ObRb. We showed that: 1) PRL-R and ObRb are expressed in the PVN and co-localized in the same neurons; 2) in lactating females leptin failed to activate JAK-2/STAT-3 signaling pathway; 3) in Chinese Hamster Ovary (CHO) stably co-expressing PRL-R and ObRb, overexposure to PRL did not affect leptin signaling but totally abolished PRL-dependent STAT-5 phosphorylation. The overexposure to leptin produces similar results with strong alteration of leptin-dependent STAT-3 phosphorylation, whereas PRL-dependent STAT-5 was not affected; and 4) CHO-ObRb/PRL-R cells overexposure to leptin or PRL induces the expression of negative regulators SOCS-3 and PTP-1B. Thus, we conclude that these negative regulators affect specifically the inducer signaling pathway; for instance, SOCS-3 induced by PRL will affect PRL-R signaling but not ObRb signaling and vice versa. Finally, the lack of cross-desensitization between PRL-R and ObRb suggests that hyperphagia observed during gestation and lactation may be attributed to a direct effect of PRL on NPYexpression, and is most likely exacerbated by the physiological leptin resistance state.
Introduction
During pregnancy and lactation, increased appetite and food intake anticipates the changes in metabolic demand of these physiological conditions (Rosso 1987 , Grattan et al. 2001 . Maternal homeostatic regulators are set at new levels to allow the mother to cope with metabolic physiological demand of pregnancy and lactation. This adaptive state is driven by hormonal changes that take place in the brain of the mother. Prolactin (PRL) and leptin are among the hormones that show significant plasma level changes during these periods. During pregnancy and lactation, other hormones may also contribute to hyperphagia. The lack of central oxytocin action may partly contribute to maternal hyperphagia (Douglas et al. 2007) . Progesterone also stimulates appetite and food intake in the female in the presence of elevated leptin (Rosso 1987 , Grueso et al. 2001 .
Leptin, the 16 kDa peptide hormone product of the ob gene, is mainly produced by adipose tissue and acts at the hypothalamus to decrease food intake. Leptin also plays key roles in reproduction such as puberty onset and ovarian, testicular, and uterine functions (Chehab et al. 1996 , Hoggard et al. 1997 , Zamorano et al. 1997 , Kitawaki et al. 2000 . During pregnancy, plasma leptin levels at mid-gestation and so on are high when compared with non-pregnant females (Kawai et al. 1997 , Tomimatsu et al. 1997 , Lewandowski et al. 1999 associated with increased or unchanged food intake, suggesting a leptin resistance state (Shirley 1984 , Rosso 1987 . Moreover, recent studies show that ObRb mRNA levels in the ventromedial hypothalamic nucleus (VMH) are significantly reduced during pregnancy, and that levels of leptininduced STAT-3 phosphorylation were specifically suppressed in the VMH and arcuate nucleus (ARC) of pregnant rats compared with non-pregnant rats (Grattan et al. 2007) . The source of hyperleptinemia during pregnancy originates in humans from the placenta and adipose tissue (Masuzaki et al. 1997) , and in rodents from the adipose tissue (Kawai et al. 1997 , Tomimatsu et al. 1997 . During lactation, plasma leptin levels return to the levels observed in non-pregnant rat females (Seeber et al. 2002) or reduce by about 50% compared with non-lactating animals (Brogan et al. 1999 , Denis et al. 2003 . In pregnant women, plasma leptin levels are maintained high (Mukherjea et al. 1999) .
PRL plays a crucial role during pregnancy and lactation by exerting numerous effects on the central nervous system such as induction of maternal behavior, stimulation of oxytocin neurons, increasing appetite and food intake, suppression of adrenocorticotrophin secretion in response to stress, and suppression of fertility. In addition, PRL is involved in lobuloalveolar development of the mammary gland and differentiation of mammary cells (Bole-Feysot et al. 1998) . PRL plasma levels are maintained high during late pregnancy by reduced tonic inhibitory influence of tuberoinfundibular dopamine neurons, and during lactation where suckling exerts a strong stimulatory effect on PRL release (Freemark 2001 , Grattan 2002 .
During the late pregnancy period, females show increased leptin and PRL plasma levels along with increased food intake suggesting that leptin fails to exert its anorexic action leading to leptin resistance. Furthermore, in virgin female rats, PRL significantly increases food intake when injected into the paraventricular nucleus (PVN; Sauvé & Woodside 2000 , Woodside 2007 ). Thus, PRL may have a direct effect on food intake through NPYexpression in hypothalamic dorsomedian nucleus, where NPY-positive neurons express PRL-R mRNA (Chen & Smith 2004) . It has also been shown that during lactation the expression of NPY raised in various locations of the hypothalamus such as arcuate and dorsomedial nuclei (Chen & Smith 2004) .
Taken together, these data suggest that the orexigenic effect of PRL is predominant and attenuates the anorexic effect of leptin in the hypothalamus during late pregnancy. The effect of PRL may be attributed to a direct effect on the expression of NPY or through the inhibition of leptin action.
In our study, we focused mainly on PRL and leptin. These cytokines share a number of signaling pathways acting through cytokine class I receptors. Long isoforms of PRL and leptin receptors (ObRb) act respectively through JAK-2/STAT-5 and JAK-2/STAT-3 signaling pathways (Bjorbaek et al. 1997 , Bole-Feysot et al. 1998 . Both pathways induce the expression of suppressor of cytokine signaling 3 (SOCS-3), which is a negative regulator of both hormones (Ihle 1995) . We hypothesize that during pregnancy, due to high PRL plasma levels, PRL activates the PRL-R/JAK-2/ STAT-5 pathway and induces SOCS-3 resulting in inhibiting leptin action and subsequent increase in food intake. In the present study, we first showed that both PRL-R and ObRb receptors are co-expressed in the same neurons in hypothalamic areas involved in the control of food intake such as the PVN. Secondly, to investigate a possible cross-talk between PRL-R and ObRb, Chinese Hamster Ovary (CHO) cells were stably co-transfected with cDNAs encoding for both receptors. In co-transfected cells, PRL pre-treatment did not affect ObRb signaling despite SOCS-3 induction and vice versa. Thus, PRL and leptin downregulate their own signaling with no cross-desensitization.
Materials and Methods

Animals
Lactating and virgin female rats were housed under a 12 h light:12 h darkness cycle with access to food and water ad libitum and used in accordance with French and European ethics authorities and local regulations.
Tissues preparation for brain slice experiments
Four virgin and lactating female rats were rapidly decapitated without anesthesia, and their brains removed immediately and transferred into ice-cold oxygenated Krebs-Henseleit buffer (Sigma) added to 25 mM NaHCO 3 , 2 mM CaCl 2 , 11 mM glucose, 60 mM ascorbic acid, and 31 . 5 mM thiourea. Three hundred micrometers thick hypothalamus slices were prepared and warmed to 35 . 5 8C in Krebs bicarbonate buffer. After 30-min incubation, 1 mg/ml leptin or PRL were added in the incubation medium for 10 min. By micropunch, the arcuate nucleus were recuperated and incubated in an ice-cold lysis buffer (20 mM Tris-HCl (pH 7 . 5), 1% Nonidet P-40, 1% Triton X-100, 10% glycerol, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, protease inhibitors (0 . 35 mg/ml phenylmethylsulfonyl fluoride (PMSF), 2 mg/ml leupeptin, 2 mg/ml aprotinin), and phosphatase inhibitors (1 mM Na 3 VO 4 , 10 mM sodium fluoride, 20 mM sodium b-glycerophosphate, 10 mM benzamidine)), and then sonicated (Elmasonic, Fisher Bioblock Scientific, Illkirch, France) for 10 min. Lysates were clarified by centrifugation at 15 300 g for 40 min and supernatants kept for western blot analyses. Protein concentrations of supernatants were determined using a protein assay kit (Pierce, Perbio Science, France).
Cell culture: stable and transient transfections CHO cells were grown in HAM-F12 supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin/streptomycin, and 100 U/ml glutamine at 37 8C in 5% CO 2 . The cDNA encoding mouse ObRb and PRL-R were produced as described previously (Edery et al. 1989 , Bjorbaek et al. 1997 . Cells were double transfected with ObRb and PRL-R expression vectors carrying geneticin and hygromycin resistance respectively. Selected double-transfected cells (CHO-ObRb/PRL-R) were cultured in a medium containing both antibiotics.
CHO cells stably expressing ObRb were transiently transfected with various concentrations of PRL-R expression vector DNA (1-5 mg).
Cell stimulation and western blot analysis
Cells were grown in 10 cm dishes and serum deprived for 16 h before stimulation with hormones. Acute and chronic PRL and leptin treatments were performed on CHO-ObRb/PRL-R. For acute stimulations, cells were incubated in serum-free medium in the presence or absence of various concentrations (as indicated in the figures) of leptin or PRL for 10 min. In the kinetic studies, cells were incubated in the absence or presence of 500 ng/ml leptin or PRL for various time periods. For chronic treatment, cells incubated in serum-free medium in the absence or presence of 500 ng/ml leptin or PRL for 16 h, then washed, and acutely stimulated for 10 min by leptin or PRL. Following these treatments, cells were harvested by rinsing in ice-cold PBS and scraping into 500 ml ice-cold lysis buffer (20 mM Tris-HCl (pH 7 . 5), 1% Nonidet P-40, 1% Triton X-100, 10% glycerol, 150 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , protease inhibitors (0 . 35 mg/ml PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin), and phosphatase inhibitors (1 mM Na 3 VO 4 , 10 mM sodium fluoride, 20 mM sodium b-glycerophosphate, 10 mM benzamidine)). Lysates were clarified by centrifugation at 15 300 g for 40 min and supernatants kept for western blot analyses. Protein concentrations of supernatants were determined using a protein assay kit (Pierce). Cell proteins (30 mg) were resolved in SDS-PAGE followed by western blot using adequate antibodies (as indicated in the Results section). Then, western blot bands were revealed by enhanced chemiluminescence (ECL).
Immunohistochemistry
Three female rats were anesthetized with sodium pentobarbital (25 mg/kg). Brain fixation and sectioning were performed as described previously (Vacher et al. 2002) . Coronal brain sections (50 mm) were cut on a vibroslicer (1000Plus, Harvard Apparatus, Holliston, MA, USA) and blocked for endogenous peroxidase in 1% H 2 O 2 . Sections were incubated for 24 h at 4 8C with mouse anti-PRL-R (1:200; Affinity BioReagents, Golden, CO, USA) or rabbit anti-ObRb prepared in our laboratory, and revelations performed as described previously (Vacher et al. 2002) . Control experiments were performed by omitting the primary antibodies. For the double immunofluorescence procedure, coronal 50 mm thick sections were incubated simultaneously with mouse anti-PRL-R and rabbit antiObRb antibodies for 24 h at 4 8C. The simultaneous visualization of the two primary antisera was performed with Fluor Probes 488 conjugated donkey anti-rabbit and tetra methylrhodamine isothiocyanate (TRITC)-conjugated donkey anti-mouse immunoglobulins (1:400). After washing, brain sections were mounted with Vectashield. Double immunofluorescence was investigated using an ArgonKrypton laser (Bio-Rad MRC 1024 ES laser, Marnes la Cognette, France) scanning confocal microscope coupled to a Nikon Diaphot 300.
Cross-over fluorescence can be ruled out, as spectra of both fluorochromes do not overlap. Each optical section (1 mm) was averaged thrice. The free software ImageJ (http://rsb.info.nih. gov/ij) was used to work captured pictures. In the case of double immunohistochemistry, figures resulted due to the projection of 13 successive optical sections, and in the case of zoom optical, projection of 10 sections. Co-localization pictures were the combination of each corresponding fluorescent signal.
Chemicals
The ObRb expression vector was a generous gift from Dr Christian Bjorbaeck. Ovine leptin was produced as described previously (Gertler et al. 1998) . Antibodies directed toward total STAT-3 and 5, phospho-STAT-3 and 5 were obtained from Cell Signaling (Ozyme, St Quentin en Yvelines, France). The ECL detection system was from Amersham. Fluor Probes 488 conjugated anti-rabbit was from Interchim (Montluçon, France). TRITC-conjugated anti-mouse and anti-rabbit IgG conjugated to horseradish peroxidase were from Sigma. Vectashield was from Vector Laboratories (Burlingame, CA, USA).
Results
Leptin resistance in lactating female rats
To determine leptin sensitivity of hypothalamic arcuate nucleus, hypothalamic slices of virgin and lactating female rats were incubated in the presence or absence of leptin (1 mg/ml) for 10 min. Following the western blot analysis, leptin significantly induced STAT-3 phosphorylation in virgin females, whereas in lactating females, this was completely abolished (Fig. 1) . Co-localization of ObRb and PRL-R in the hypothalamic PVN
In the PVN, ObRb-immunoreactive cells occupied the major part of the nucleus ( Fig. 2A) , both in parvocellular and magnocellular neurons. This staining was primarily observed in cell bodies. Confocal microscopy scanning at higher magnification revealed a punctiform staining throughout the cytoplasm of neurons ( Fig. 2C and F) . However, PRL-Rimmunopositive cells were mostly observed in the peripheral part of the PVN (Fig. 2B) , namely in magnocellular neurons. PRL-R immunoreactivity exhibited a somatic punctiform staining similar to that of ObRb ( and G). The double immunostaining experiments revealed a co-localization of ObRb and PRL-R in the magnocellular neurons ( Fig. 2E and H) . Arrows in Fig. 2E indicate cells co-expressing both ObRb and PRL-R. The insert d in panel E represents a focal plan (in insert a, x and y field) of one neuron (insert a) and illustrates co-localization of ObRb (insert b) and PRL-R (insert c).
Stable transfection of ObRb and PRL-R in CHO cells (CHO-ObRb/PRL-R)
To determine the possible cross-regulation between leptin and PRL signaling pathways, CHO cells were stably transfected with ObRb and PRL-R cDNAs. The functionality of both receptors was evaluated by the measurement of STAT-3 and 5 phosphorylation in response to leptin and PRL stimulations respectively. Leptin induced the phosphorylation of STAT-3 in a dose-dependent manner and the phosphorylation was detected already with 5 ng leptin/ml (Fig. 3A) . The dosedependent effect was assessed in three separate experiments and the mean results are presented in Fig. 3B . In addition, when 500 ng leptin/ml were used, the kinetics of STAT-3 phosphorylation revealed a peak at 10 min after incubation and then gradually decreased (Fig. 3C) . The mean results indicate that leptin significantly induced STAT-3 phosphorylation levels from 5 to 30 min, then decreased, and returned to the basal level (Fig. 3D) . Similar results were obtained for STAT-5 phosphorylation in response to PRL. PRL induced a dose-dependent effect with a significant increase in STAT-5 phosphorylation with 250 and 500 ng PRL/ml ( Fig. 4A and   B ). The kinetics of STAT-5 phosphorylation in response to PRL reached its maximum after 5-10 min of incubation and then declined to reach basal values ( Fig. 4C and D) .
Impact of chronic PRL or leptin treatment on CHO-ObRb/PRL-R cells sensitivity to both hormones
To investigate the possible cross-regulation between ObRb/ JAK-2/STAT-3 and PRL-R/JAK-2/STAT-5 signaling pathways, CHO-ObRb/PRL-R cells were pre-treated with or without leptin (500 ng/ml) or PRL (500 ng/ml) for various time periods (0 h, 1 h, 2 h, 4 h, and 16 h) and then stimulated for 10 min with either PRL or leptin. The western blot analyses of cell lysates were performed by anti-phospho-STAT-3 or 5 antibodies. Results were normalized to either total STAT-3 or 5.
In leptin pre-treated cells, leptin-dependent phosphorylation of STAT-3 was completely abolished from 1 h of pretreatment ( Fig. 5A and B) . In contrast, PRL-dependent phosphorylation of STAT-5 was not affected and remained significantly high independent of leptin pre-treatment duration ( Fig. 5C and D) .
In PRL pre-treated cells, PRL-dependent phosphorylation of STAT-5 was completely abolished from 1 h of pretreatment ( Fig. 6A and B) , whereas leptin-dependent STAT-3 phosphorylation was not affected at all by PRL pre-treatment ( Fig. 6C and D) .
To determine whether the absence of cross-regulation between PRL-R and ObRb was attributed to an inadequate ObRb/PRL-R ratio expressed on CHO cells, CHO-ObRb cells stably expressing ObRb were transiently transfected with increasing amount of PRL-R cDNA (1-5 mg/dish). In these cells, STAT-5 phosphorylation was estimated after PRL stimulation. PRL increased STAT-5 phosphorylation in a PRL-R cDNA dose-dependent manner (Fig. 7A ). STAT-3 phosphorylation was estimated in response to leptin following PRL pre-treatment. Despite PRL pre-treatment, leptin clearly increased STAT-3 phosphorylation independent of transfected amount of PRL-R cDNA (Fig. 7B) . 
The lack of cross-regulation between ObRb and PRL-R does not involve SOCS-3 nor PTP-1B
The absence of cross-regulation between leptin and PRL signaling pathways in CHO-ObRb/PRL-R cells has raised a question concerning the induction of the common negative regulators SOCS-3 and PTP-1B. To evaluate these inductions, cells were incubated for various time periods with leptin and/or PRL (1-16 h), and then SOCS-3 and PTP-1B were estimated by western blot using specific antibodies. Treatment with leptin or PRL induced SOCS-3 expression, and this expression remained significantly high over 16 h of incubation ( Fig. 8A  and B) . PTP-1B was also significantly induced by both leptin and PRL from 1 h of treatment ( Fig. 8C and D) .
Discussion
Significant changes occur in hormonal status and energy intake in mammalian females during gestation and lactation, as are mirrored by hyperprolactinemia, hyperleptinemia, and hyperphagia (Garcia et al. 2000 , Grattan 2002 ). It has been suggested that hyperprolactinemia and hyperphagia are most likely linked through the activation of the orexigenic neuropeptide Y (NPY) expression by PRL in several hypothalamic nuclei involved in the control of food intake, and specifically in the PVN (Chen & Smith 2004) . Several reports have also demonstrated that leptin levels are high in serum during human and rodent gestation (Chien et al. 1997 , Lage et al. 1999 . During lactation, leptinemia is maintained at the levels observed in non-pregnant females (Kawai et al. 1997) . Thus, the resulting hyperphagia observed during gestation and lactation indicates a physiological state of leptin resistance in the hypothalamus. In this hormonal environment, the hyperphagic behavior could also be attributed to hyperprolactinemia through the induction of NPY expression. In the present paper, we attempted to understand the possible cross-talk between PRL-R and ObRb signaling pathways to establish whether the leptin resistance observed during gestation and lactation results from the inhibition of ObRb signaling pathways by PRL. STAT-5 and 3 phosphorylation were respectively estimated by western blot in response to 500 ng PRL/ml after 10 min of treatment (A) and 500 ng leptin/ml after 10 min of treatment following a pretreatment for 4 h in the presence of 500 ng PRL/ml (B). Total STAT-5 and 3 were also determined. All experiments were performed in duplicate in two independent experiments.
The possible cross-talk between leptin and PRL signaling pathways in the hypothalamus could have a physiological relevance, because we first showed that in the female rat hypothalamus both PRL-R and ObRb are expressed in the PVN. Interestingly, both the receptors co-localize in the same neurons. To our knowledge, this is the first evidence for such co-localization, which is a prerequisite for a possible cross-talk between both receptor signaling pathways. Moreover, by brain slice experiments, we showed that virgin females are sensitive to leptin, whereas lactating females are leptin resistant. To investigate this putative cross-regulation between ObRb and PRL-R, CHO cells stably co-transfected with PRL-R and ObRb were produced. In these cells, leptin and PRL clearly induced the phosphorylation of STAT-3 and 5 respectively. The phosphorylation of STAT-3 and 5 in response to leptin and PRL respectively increased over the first 30 min of incubation with a maximum being achieved after 10 min of treatment and then declined from 60 min of incubation. To mimic gestation or lactation hormonal environment, CHO-ObRb/PRL-R were subjected to PRL pre-treatment. In this condition, PRL-R signaling was completely abolished, as mirrored by a clear desensitization of PRL-R/STAT-5 signaling pathway in response to PRL stimulation. In contrast, the ObRb/STAT-3 signaling pathway was not affected by PRL pre-treatment and leptin still clearly increased STAT-3 phosphorylation. Similar results were obtained when cells were subjected to leptin overexposure. The ObRb/STAT-3 signaling pathway was completely inhibited and a clear leptin resistance is shown, whereas the PRL-R/STAT-5 signaling pathway was not affected and PRL sensitivity was not altered. Our results thus indicate the absence of cross-regulation between PRL-R and ObRb. However, as this result could be attributed to an inappropriate ratio of PRL-R/ObRb expressed at the cell surface. CHO cells stably expressing ObRb were transfected with increased amount of PRL-R expressing vector. The ObRb/STAT-3 signaling pathway in those cells was also not affected by PRL overexposure, thus confirming our previous data and indicating the lack of a cross-desensitization between PRL-R and ObRb.
Interestingly, the common negative regulator SOCS-3 was induced by both leptin and PRL overexposure. Our results establish that the induction of SOCS-3 in response to long-term stimulation by leptin or PRL is only able to shut down the signaling of the inducer receptor. For instance, PRL treatment reduces PRL-R signaling but not leptin signaling and vice versa. These results contrast with previous studies that have described a negative cross-talk between interleukin-3 and interleukin-11 through the induction of SOCS-3 (Magrangeas et al. 2001) . It is, however, shown that growth hormone (GH) pre-treatment of adipocytes does not affect STAT-3 phosphorylation induced by cardiotropin-1a (CT1) or ciliary neutrophic factor (CNTF), which belong to interleukin-6 family but completely abolished GH-dependent STAT-5 phosphorylation (Zvonic et al. 2005) . This is in good agreement with our findings, since GH induced SOCS-3 expression without affecting CT1 or CNTF signaling. Furthermore, we have also shown that both leptin and PRL long-term pre-treatment induced PTP-1B. To our knowledge, this is the first study to show such induction. Despite the increased PTP-1B following PRL exposure, ObRb signaling was not altered and this contrasts with previous studies (Lund et al. 2005) which have demonstrated that PTP-1B clearly reduced the phosphorylation of STAT-3 and JAK-2 in response to leptin. Taken together, our data suggest the absence of crosstalk between PRL-R and ObRb signaling pathways despite the significant induction of similar negative regulators such as SOCS-3 and PTP-1B. The hypothesis of intracellular compartmentalization could be a possible explanation suggesting that the induced negative regulator will only affect the inducer receptor. The compartmentalization has been Figure 8 Leptin and PRL induce SOCS-3 and PTP-1B in CHO-ObRb/PRL-R cells. CHO cells stably co-expressing ObRb and PRL-R were starved and pre-treated with leptin or PRL (500 ng/ml) for various time periods. SOCS-3 (A and B) and PTP-1B (C) were estimated by western blot using specific antibodies, results are normalized to b-tubulin. SOCS-3 and PTP-1B expression was measured in three independent experiments and the results expressed as meanGS.E.M.; *P!0 . 05 and **P!0 . 005.
suggested for several signaling pathways such as MAP kinases (Caunt et al. 2006) , protein kinase A (Ghil et al. 2006) , and tumor necrosis factor (TNF) receptor 1 signaling pathways (Hunter & Nixon 2006) .
If this concept is generalized in vivo, this should indicate that the hyperphagia observed during gestation and lactation can not be attributed to the inhibition of leptin signaling through the induction of SOCS-3, but is probably attributed to the direct effect of PRL on the expression of NPY at the hypothalamic level, as suggested previously (Freemark 2001) . However, leptin resistance observed in these physiological states may have an additive effect by exacerbating food intake.
